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Abstract 
Background: Obesity rates are higher among females than males potentially due to changing 
food intake across the menstrual cycle.  Food intake is partially regulated by circulating appetite-
regulating hormones that can be influenced by the menstrual hormones estradiol and 
progesterone. Purpose: Examine whether changes in female sex hormones across the menstrual 
cycle are related to appetite-regulating hormones. Methods: 8 healthy young females were 
tested during the follicular, ovulatory, and luteal phases; phases were confirmed by fasting 
plasma hormone concentrations.  Blood samples were taken after an overnight fast, as well as 
30, 60, and 90 min post-prandially to test the concentrations of acylated ghrelin and active GLP-
1.  Perceived hunger, fullness, satisfaction, and prospective food intake were collected 
immediately prior to blood samples.  Resting metabolic rate and substrate oxidation were tested 
through indirect calorimetry. Results:  Menstrual cycle phase had no effect on acylated ghrelin 
(P=0.959) or active GLP-1 (P=0.650). Post-prandial fullness was greater during the OP 
compared to FP (P=0.02) and approached significance with the LP (P=0.06) but there was no 
difference in other perceptions of appetite.  There was no effect of menstrual cycle phase on 
resting metabolic rate (P=0.961), carbohydrate oxidation (P=0.603), or fat oxidation rate 
(P=0.485).  Conclusion:  Acylated ghrelin and active GLP-1 are unlikely to explain the 
previously documented changes in energy intake across the menstrual cycle though perceived 
fullness can be elevated during the luteal phase.  Taken together, this suggests that sensitivity to 
appetite-regulating hormones might fluctuate across the menstrual cycle. 
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Chapter 1 - Literature Review 
Background: 
Obesity has become a worldwide epidemic afflicting ~1.6 billion people worldwide (1).  
A majority of Canadians are currently overweight or obese (2) with an economic burden of $4.3 
billion in 2004, ~2.5% of total health care costs (3).  Obesity is generally caused by a sustained 
increase in energy intake  (i.e. over eating) and decreased energy expenditure (i.e. increasingly 
sedentary behaviour).  Together these produce a chronic positive energy balance that inevitably 
leads to increased storage of energy, primarily as fat.  At the same time, rates of obesity (body 
mass index >30) and morbid obesity (body mass index >40) are higher among females than 
males (4,5) and overweight females are more likely to become obese compared to overweight 
males (6).  Unfortunately, despite ~52% of Canadian females currently trying to lose weight (7), 
exercise interventions are often far less effective at improving body composition in females than 
males (8-11).  The difficulty females experience with weight management might be partly 
explained by fluctuations in female sex hormones, namely estradiol and progesterone, associated 
with the menstrual cycle as these hormones are known to influence energy intake and energy 
expenditure (12-16).  Unfortunately, females remain largely under-researched in physiology (17) 
making it imperative to conduct studies on female-specific physiology to understand the 
aforementioned problems that females experience with weight management.   
Appetite Regulation: 
Overview.  The control of energy intake is a complex system incorporating psychological, social, 
environmental, behavioural, and physiological components (18).  The complexity of appetite 
regulation makes it exceedingly difficult to determine how any single factor will contribute to 
actual energy intake.  Moreover, the difficulty controlling for environmental and social factors 
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makes understanding the more readily modifiable factors that influence eating behaviour, such 
as appetite-regulating hormones, important for developing our understanding of appetite 
regulation.	  Physiologically, circulating gut-derived endocrine signals acutely respond to feeding 
and also reflect total adiposity and energy balance to regulate energy intake (19).  These 
circulating hormones are integrated in the arcuate nucleus (ARC) of the hypothalamus to 
mediate hunger, satiety, and energy intake (20,21).  Currently the only known orexigenic 
(appetite-stimulating) gut-derived hormone is ghrelin, secreted from the stomach, that induces 
hunger by stimulating the NPY and AgRP neurons in the ARC (22).  Whereas, there are 
numerous anorexigenic (satiety-inducing) hormones, including glucagon-like peptide-1 (GLP-1) 
that creates satiating effects through delaying gastric emptying and incretin effects (20) (Figure 
1).  
 
Ghrelin.  Ghrelin is a 28-amino acid peptide hormone synthesized predominantly by specialized 
cells in the stomach (22).  Recently it has become possible to accurately measure acylated 
ghrelin (AG), the active form of ghrelin.  Acylation of ghrelin involves the addition of an 
octanoyl group by the enzyme ghrelin O-acyl transferase (23) and is rapidly degraded if not 
inhibited (22,24).  Although AG represents only 10-20% of total circulating ghrelin it is believed 
to be more important in regards to appetite stimulation (25).  
 In animal models, exogenously administered ghrelin increases energy intake (26).  
Similarly, elevated concentrations of ghrelin stimulates energy intake in humans (26).  
Moreover, circulating ghrelin concentrations increase while fasting and rapidly decrease after 
eating (26-28), peaks in ghrelin precede increased perceptions of hunger by only a short time 
(29), are strongly associated with perceptions of hunger (30).  Taken together, these data 
11	
	
implicate ghrelin in the stimulation of hunger and energy intake.  Concentrations of AG are 
suppressed within min of food consumption and begin to rise around 1.5-2 h post-prandially 
(30), although this can be modulated by various factors, including macronutrient composition 
(31) or an individual’s body composition (32).  
  
Glucagon-like peptide (GLP-1).  GLP-1 is an anorexigenic gut-derived peptide secreted 
primarily from the small intestine (33).  Bioactive GLP-1 is generated from two circulating 
forms, GLP-17-37 and GLP-17-36 (34).  Both forms of GLP-1 are equally potent (34) but in human 
plasma GLP-17-36 represents the majority of active circulating active GLP-1 (35).  Following 
Figure 1: Schematic of gut-derived appetite-regulating hormones and the mechanisms through which 
they control energy intake.  Ghrelin stimulates hunger by interacting with NPY/AgRP neurons in the 
arcuate nucleus.  GLP-1 functions through non-hypothalamic mechanisms, including incretin effects and 
delaying gastric emptying.  Continuous lines represent stimulatory effects while dashed lines represent 
inhibitory effects. 
12	
	
release, GLP-1 is rapidly degraded by dipeptidyl peptidase-4 (DPP-IV) to its inactive form GLP-
19-36 (34).   
 In animals, the absence of GLP-1 produces bodyweight gain due to increased energy 
intake compared to GLP-1 replete animals (36).  In humans, increased concentrations of GLP-1 
decrease hunger (37) and reduce energy intake (38).  These data reflect GLP-1’s anorexigenic 
effects.  GLP-1 concentrations begin to increase within min of food ingestion and remain 
elevated for ~1 h (33).  Similarly to ghrelin, secretion of GLP-1 can be influenced by 
macronutrient composition (39) or an individual’s body composition (40). The mechanisms by 
which GLP-1 induces satiety likely include stimulating insulin secretion, inhibiting the release of 
glucagon, and delaying gastric emptying (41).   
 
The Menstrual Cycle: 
Basic Physiology.  The menstrual cycle is regulated by the interaction of pituitary hormones, 
including gonadotropin-releasing hormone, luteinizing hormone (LH), follicle-stimulating 
hormone (FSH), and the ovarian hormones progesterone and estrogen (Figure 2) (42).  There are 
various forms of estrogen but estradiol is the most biologically active form in young healthy 
women (16,17).  The female menstrual cycle can be divided into discrete phases based on its 
hormonal profile.  For instance, the follicular phase (FP) beings with menses, ends at ovulation, 
and is characterized by relatively low concentrations of estradiol and progesterone (43).  Near 
the end of the FP there is a surge of estradiol that triggers the secretion of LH and FSH to induce 
ovulation.  Once ovulation (i.e. release of the oocyte/egg) has occurred, the resulting corpus 
luteum within the ovary begins to secrete large amounts of progesterone.  Consequently, the 
luteal phase (LP) is characterized by a progesterone-dominated state, although estradiol is also 
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elevated relative to the FP (44).  The LP lasts from ovulation until menses of the next menstrual 
cycle (45).  While previous research has demonstrated that gonadotropin-releasing hormone, LH, 
and FSH do not correlate with eating in female rats (46), estradiol and progesterone play an 
important role in energy intake. 
 
Menstrual Cycle and Energy Intake.  It is well documented that energy intake fluctuates 
throughout the menstrual cycle and that changes coincide with fluctuations in ovarian hormones 
(15,47-49) (Figure 3).  Daily energy intake is lowest during ovulation (13,14,46) which is 
attributed to the anorexigenic effects of estradiol.  Following ovulation, energy intake increases 
by up to 90-500 kcal/day, or an increment of 3.9-34.7%, during the LP compared to the FP 
(15,50-53).  The increased energy intake potentially reflects the anti-estrogenic and orexigenic 
properties of progesterone (45,54).  Indeed, females may consume ~10% more during one-half 
of their menstrual cycle which is certainly capable of influencing energy balance (46) and 
eventually body weight.  Importantly, these changes in energy intake are explained entirely by 
differences in the caloric intake at each meal, as opposed to changes in the frequency of energy 
intake (46,55).  Therefore, it seems reasonable to speculate that distinct hormonal responses 
occur post-prandially during each menstrual phase.  For example, AG might decrease more 
rapidly or profoundly post-prandially during the OP, thereby reducing perceptions of hunger and 
energy intake in this phase.  In this light, it is particularly important for research to investigate 
how appetite-regulating hormones respond to feeding throughout the menstrual cycle.  
 
Menstrual Cycle and Appetite-Regulating Hormones.  In light of the aforementioned changes in 
energy intake across the female menstrual cycle, it is conceivable that female sex hormones are 
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altering hormones that regulate energy intake.  Estradiol is a potent anorexigenic agent that is at 
least partly responsible for the decreased energy intake during ovulation (48,49).  Estradiol is an 
inhibitory signal that links the hypothalamic–pituitary–gonadal axis to the neural control of 
feeding and decreases energy intake by reducing the quantity of food consumed at each meal 
(43).  Estradiol’s anorexigenic effect can be observed in ovariectomized rats who consequently 
express very low concentrations of estradiol, hyperphagia, and a 10-30% increase in body fat 
(56) and the reversal of these effects by estradiol treatment alone (57). 
	 Estradiol may produce its anorexigenic effect through interactions with appetite-
regulating gut hormones.  Indeed, diminished numbers of ghrelin-producing cells, ghrelin 
mRNA concentrations in the stomach, and plasma ghrelin concentrations were all observed 
when estradiol was exogenously administered to ovariectomized rats (58). Furthermore, total 
ghrelin no longer stimulated energy intake in ovariectomized rats who received estradiol 
infusions, implying that the orexigenic 
potency of ghrelin is diminished by 
estradiol (16).  Finally, human females with 
hypothalamic amenorrhea who 
consequently exhibit lower than average 
estradiol concentrations also express 
concomitantly greater (44%) total ghrelin 
concentrations compared to their estradiol-
replete counterparts (59).  
As ghrelin producing cells possess estradiol receptors (58), this suggests a direct 
mechanism for how AG production could be influenced by estradiol, it is less clear how GLP-1 
Figure 2: Fluctuations in female sex hormones 
and energy intake across the menstrual cycle. 
Adapted from (Hirschberg et al. 2012)1 
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could be effected.  One potential mechanism is altered gastric emptying throughout the 
menstrual cycle.  Gastric emptying is an important regulator of GLP-1 secretion (60), but 
currently there are conflicting reports on whether gastric emptying is altered by female sex 
hormones (61-63).  At the same time, there is evidence that estradiol can increase the satiating 
potency of GLP-1, although it is unclear how this occurs given that central GLP-1 receptors do 
not possess estrogen receptors (46). 
Estradiol can also influence appetite and energy intake through the stimulation of 
estradiol receptors located in various regions of the brain, especially the hypothalamus. This is 
supported by an observable decrease in eating when dilute estradiol is implanted directly into the 
hypothalamus in ovariectomized rats (64). Furthermore, the NPY/AgRP and POMC/CART 
neurons within the hypothalamus possess abundant estradiol receptors so it is possible that 
estradiol exerts its satiety effect directly through these neurons which play important roles in the 
regulation of energy intake (65-67).  
  An important limitation of utilizing the menstrual cycle to test the effects of sex 
hormones is that progesterone cannot be isolated since there is no time when progesterone alone 
is elevated (17).  For this reason, the effects of progesterone are less understood than estradiol.  
However, while progesterone alone does not seem to significantly alter energy intake in 
ovariectomized rats unless it is administered in supraphysiological doses (68) there is support for 
an orexigenic effect of progesterone in human females (69).  In particular, the increased hunger 
accompanying pregnancy has been partially attributed to the effects of progesterone on specific 
neurons in the ARC (70).  Also, food cravings are more frequent and intense during the LP 
which has been attributed to progesterone (15,69). It is possible that the orexigenic effect of 
progesterone is actually due to its antagonizing and suppressing estradiol’s effects.  Many of 
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estradiol’s metabolic actions are antagonized by progesterone (45) so it may be that progesterone 
can inhibit the anorexigenic effect of estradiol.  Although it is not exactly clear how this 
happens, when progesterone levels were artificially elevated in rhesus monkeys, estradiol levels 
were diminished and the estradiol surge that precedes ovulation did not occur (71).  Regardless 
of the specific mechanism, progesterone seems able to stimulate energy intake and weight gain 
suggesting that it could contribute to the greater energy intake in the progesterone-dominated 
LP.  
 
Menstrual Cycle and Energy Expenditure.  To fully understand how the menstrual cycle could 
influence weight maintenance it is important to examine both components of energy balance, 
namely energy intake and energy expenditure.  The greatest component of daily energy turnover 
is generally resting metabolic rate (72).  Studies consistently indicate that daily energy 
expenditure fluctuates throughout the menstrual cycle (73-77).  During the LP, energy 
expenditure can increase up to 279 kcal/day, or 2.5-11.5%, compared to the FP (43).  Elevated 
energy expenditure during the LP may result, at least in part, from the hyperthermic effects of 
progesterone (45).  Moreover, many of the changes that occur during pregnancy, a very 
energetically costly and progesterone-dominated state, are also observed during the LP, 
including a 0.3-0.5 °C increase in body temperature (45).  Taken together, these data 
demonstrate the importance of considering both energy expenditure and energy intake when 
exploring how the female menstrual cycle affects weight management.  
 
Teleological Explanation.  Compared to males, females consistently demonstrate greater 
maintenance of energy balance (>99.5% accuracy over a year) in response to acute energy 
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deficits (72,78-80).  This precise maintenance is probably driven by the relationship between 
energy balance and reproductive success in females (81).  In females, even a modest energy 
deficit can suppress ovulatory cycles and inhibit the hypothalamic–pituitary–gonadal axis (82) 
while there appears to be no major disturbances in reproductive function when large energy 
deficits exist in males (81).  Because lactation and parental thermoregulatory behaviours are 
extremely energetically costly in mammals (83) it seems intuitive that a hormonal milieu able to 
drive energy intake would exist during pregnancy.  Indeed, the increased progesterone and 
estradiol during pregnancy are similar to that during the LP.  Therefore, the LP may represent a 
“gestational-preparation stage” whereby females are preparing for pregnancy to occur, as it 
would around ovulation, the stage immediately before the LP.  This would be an evolutionarily 
pertinent function as even a small energy deficit at the early stages of pregnancy could have 
detrimental effects on fetal development.  
Summary: 
Females experience predictable fluctuations in ovarian hormones across the menstrual 
cycle and these hormones can influence energy intake and energy expenditure.  Past research on 
appetite-regulating hormones has focused on males, with the only studies on females occurring 
during the early FP (84-86) when hormone concentrations are lowest.  Although informative, 
studying one phase that represents only ~50% of adult female life provides an incomplete 
understanding and can lead to inappropriate conclusions.  Considering the interactions between 
sex and appetite-regulating hormones it seems reasonable that these could be at least partially 
responsible for the changes in energy intake across the menstrual cycle. 
 Therefore, the purpose of the current project was to investigate the effect of menstrual 
phase on appetite-regulating hormones and perceptions of appetite.  We hypothesize that 
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compared to the OP and FP, there will be elevated concentrations of AG, perceived hunger, and 
low active GLP-1 during the LP, while progesterone is increased.  Conversely, during OP, with 
its elevated estradiol concentrations, there will be lower AG but greater concentrations of active 
GLP-1 and a concomitantly reduced hunger compared to both the FP and LP.		These results will 
provide important information on the mechanisms of weight management in females.   
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Menstrual cycle phase has no effect on acylated ghrelin and GLP-1 
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Abstract 
Background: Obesity rates are higher among females than males potentially due to changing 
food intake across the menstrual cycle.  Food intake is partially regulated by circulating appetite-
regulating hormones that can be influenced by the menstrual hormones estradiol and 
progesterone. Purpose: Examine whether changes in female sex hormones across the menstrual 
cycle are related to appetite-regulating hormones. Methods: 8 healthy young females were tested 
during the follicular, ovulatory, and luteal phases; phases were confirmed by fasting plasma 
hormone concentrations.  Blood samples were taken after an overnight fast, as well as 30, 60, 
and 90 min post-prandially to test the concentrations of acylated ghrelin and active GLP-1.  
Perceived hunger, fullness, satisfaction, and prospective food intake were collected immediately 
prior to blood samples.  Resting metabolic rate and substrate oxidation were tested through 
indirect calorimetry. Results:  Menstrual cycle phase had no effect on acylated ghrelin (P=0.959) 
or active GLP-1 (P=0.650). Post-prandial fullness was greater during the OP compared to FP 
(P=0.02) and approached significance with the LP (P=0.06) but there was no difference in other 
perceptions of appetite.  There was no effect of menstrual cycle phase on resting metabolic rate 
(P=0.961), carbohydrate oxidation rate (P=0.603), or fat oxidation rate (P=0.485).  Conclusion:  
Acylated ghrelin and active GLP-1 are unlikely to explain the previously documented changes in 
energy intake across the menstrual cycle though perceived fullness can be elevated during the 
luteal phase.  Taken together, this suggests that sensitivity to appetite-regulating hormones might 
fluctuate across the menstrual cycle. 
KEYWORDS: GHRELIN, GLP-1, APPETITE, MENSTRUAL CYCLE, FEMALE, RESTING 
METABOLIC RATE 
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Introduction 
Despite ~50% of North American females currently trying to lose weight (1,2), 
overweight females are more likely to become obese compared to overweight males (3) partly 
explaining the greater rates of obesity (body mass index >30) and morbid obesity (body mass 
index >40) among females (4,5).  Moreover, university is an important time as 60% of first year 
students gain 3.5 kg (6).  In light of this, it is important we explore the regulation of energy 
intake by healthy young females to possibly prevent the progression towards unhealthy body 
weight gain.  The difficulty females experience with weight management might be explained by 
female sex hormones, namely progesterone (P4) and estradiol (E2), the most biologically potent 
form of estrogen (7,8).  These hormones fluctuate across the menstrual cycle and are known to 
influence energy intake and energy expenditure (7,9-12). 	
The female menstrual cycle can be divided into three phases based on their associated 
hormonal milieu.  The first phase is the follicular phase (FP) that is characterized by relatively 
low concentrations of both E2 and P4 and begins with menses (day 1) and continues until 
ovulation (approximately day 12) (13).  Immediately prior to ovulation (OP), between days 7-10, 
there is a surge in E2 but no change in P4 (13).  The third phase is the luteal phase (LP) during 
which time both E2 and P4 concentrations are elevated compared to the FP but is dominated by 
P4 and lasts from ovulation until the next menses.  Interestingly, relative to the FP, energy intake 
consistently decreases around OP and increases during the LP (11,12,14,15). 
Estradiol has potent anorexigenic (satiety-inducing) effects reflected by the reduced 
energy intake around ovulation (11,16).  Moreover, there is evidence that E2 can influence the 
production of ghrelin (17) as well as the potency of ghrelin (7), leptin (18), and cholecystokinin 
(19).  Conversely, the orexigenic (appetite-inducing) effect of P4 can be seen by the increased 
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energy intake during the LP when P4 concentrations spike (12,20-22).  It is not exactly clear how 
P4 affects energy intake, although it does have anti-estrogenic qualities (23) and thus might 
suppress E2’s anorexigenic effects thereby producing an orexigenic drive.  There is also evidence 
that menstrual cycle phase can alter the production of GLP-1 (24).  Importantly, during 
anovulatory cycles, where P4 does not increase in the LP, energy intake no longer increases (12) 
supporting that the fluctuating sex hormones are responsible for changing energy intake 
(21,25,26).   
The physiological control of energy intake is partly mediated by circulating gut-derived 
hormones that either stimulate appetite (i.e. orexigenic) or induce satiety (i.e. anorexigenic) (27).  
Currently the only known orexigenic gut hormone is ghrelin, synthesized predominately by 
specialized endocrine cells in the stomach, and then activated by the addition of an octanoyl 
group to acylated ghrelin (AG) (28,29).  Importantly, peaks in ghrelin precede increased 
perceptions of hunger by only a short time (30) and are strongly associated with hunger and 
energy intake (31).  Although AG represents only 10-20% of total circulating ghrelin, it is 
thought to be more important in terms of appetite regulation (32,33). In opposition, various 
hormones such as glucagon-like peptide-1 (GLP-1) induce satiety (27).  Active GLP-1 exists in 
two equipotent forms, GLP-17-36 and GLP-17-37, although GLP-17-36 represents a majority of the 
circulating active GLP-1 (34).  GLP-1 is secreted within min of food ingestion and persists for 
up to one h post-prandially (35).  GLP-1 can suppress appetite (36), reduce energy intake (37), 
and active GLP-1 is negatively associated with hunger and energy intake (31).  Together, these 
data support that these gut-derived hormones are important in appetite regulation and energy 
intake. There is evidence that female sex hormones can influence AG (17,38) and GLP-1 (24) 
29	
	
but it is not known whether fluctuations in E2 and P4 across the menstrual cycle can have an 
effect.  
To gain a more comprehensive understanding of the effect of menstrual cycle phase on 
energy balance it is important to examine both energy intake and energy expenditure.  Indeed, it 
might be speculated that a change in energy expenditure could alter energy intake, or vice versa.  
A number of studies indicate that 24-h energy expenditure can increase by as much as 89–279 
kcal/day during the LP compared to the FP (13).  Accordingly, increased sleeping metabolic rate 
(39,40), basal metabolic rate (41), and 24-h energy expenditure (42,43) have all been reported 
during the LP.  Thus, because energy expenditure and energy intake can fluctuate across 
menstrual phases it is important to simultaneously collect these data from the same group of 
females across a single menstrual cycle.  
Changes in energy intake across the menstrual cycle are explained entirely by differences 
in the caloric intake at each meal, as opposed to changes in the frequency of energy intake 
(19,44).  Therefore, it seems reasonable to speculate that distinct post-prandial hormonal 
responses would occur during each menstrual phase.  For example, post-prandially AG might 
decrease more rapidly or profoundly during the OP, thereby reducing perceptions of hunger and 
energy intake in this phase.  Therefore, the purpose of this project was to investigate fasting and 
post-prandial AG and active GLP-1 concentrations throughout the menstrual cycle.  We 
hypothesized that the LP, with increased P4, would be associated with greater concentrations of 
AG, low active GLP-1, and a greater perceived hunger.  During OP, with high concentrations of 
E2, there would be lower AG but greater concentrations of active GLP-1, and a concomitantly 
diminished perceived hunger.  These results will provide important information on appetite-
regulation in females. 
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Methods 
Participants. Eight healthy females volunteered to participate in the current project (age: 
23.5±5.0 y; BMI: 24.15±3.15 kgm-2).  Prior to study initiation, the experimental procedures and 
potential risks were explained fully, and all participants provided written, informed consent.  The 
Wilfrid Laurier University Ethics Committee for Research on Human Subjects approved this 
study. 
Participants were between the ages of 18 and 35, recreationally active (exercising ≤3 
sessions/wk), healthy, non-smokers, eumenorrheic for at least 1 y (regularly occurring menstrual 
cycle lasting 24-35 d) based off self-reported menstrual history (23), menstruating for at least 3 y 
(45), and had not been pregnant in the past 3 y nor were planning to become pregnant at the time 
of data collection.  Females were either non-hormonal contraceptive users for a minimum of 6 
months or were using a tri-phasic hormonal contraceptive continuously for >1 y.  Tri-phasic pills 
suppress endogenous hormone production thereby providing a consistent and predictable 
hormonal milieu while decreasing inter- and intra-variability in hormone concentrations (46).  
Despite having far greater biological activity (up to 100X compared to natural forms) (47), 
synthetic sex hormones in combined oral contraceptives produce a hormonal environment 
similar to naturally fluctuating females (46).  Moreover, tri-phasic contraceptives have been 
included in past studies on appetite-regulating hormones (48,49) and various forms of oral-
contraceptives do not affect food choice or energy intake (50,51).  Participants provided a 
detailed menstrual cycle history of at least the past three cycles.  Day 1 of the menstrual cycle 
was characterized by the onset of menses.  Menstrual phase was subject-monitored by oral body 
temperature taken upon awakening with a sustained increase of ~0.3 ºC identifying ovulation 
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(23); participants reported their temperature each morning via email.  All phases were 
subsequently confirmed by hormonal testing of fasting plasma E2 and P4 collected on study days. 
Experimental Design.	 	Participants had their hormonal concentrations and energy expenditure 
measured during all three menstrual phases. Additionally, during each phase we assessed 
perceptions of hunger, fullness, prospective energy intake, and food preference using visual 
analogue scale (VAS). Each participant underwent a familiarization session before the first 
experimental session followed by three experimental sessions (~3 h).  During familiarization, 
participants became accustomed with the respiratory mask, VAS, and blood sampling 
procedures.  Participant sessions were systematically rotated to minimize any order effects.  
Participants were instructed to not engage in any strenuous physical activity for 48 h and 
to refrain from caffeine and eating the morning of a session.  Participants kept detailed food logs 
24 h before all sessions such that energy intake could be replicated before subsequent sessions. 
Participants arrived at the laboratory at 0800 h after an overnight fast (>10 h).  Upon arrival, 
participants were fitted with a respiratory mask that was worn continuously for 30 min.  
Following gas collection, appetite was assessed using VAS.  Immediately afterward, the first 
blood sample was collected (0845 h) to test fasting hormone concentrations.  After the first blood 
sample participants were served a standardized breakfast (chocolate chip Clif bar, CA, USA; 29 
kJkg-1 body weight) to be consumed within 15 min and were given 30 min for digestion.  After 
this, participants completed three VAS assessments immediately before blood samples collected 
30 (0930 h), 60 (1000 h), and 90 min post-prandially (1030 h); similar sampling times have been 
used in the past to determine changes in AG (32,33) and GLP-1 (52).  
Gas Collection.	 	Gas exchange was measured continuously for 30 min prior to eating.  All gas 
exchange measurements (VO2, VCO2, respiratory exchange ratio) were made using an online 
32	
	
breath-by-breath gas collection	and analysis system (Max II, AEI Technologies, Pittsburgh, PA, 
USA).  Prior	 to data collection the gas analyzer was calibrated with gases of	 known 
concentrations and flow with a 3-L syringe.  All measures	were collected while participants were 
seated in a	temperature-controlled room (~21 °C).  The resting VO2 and VCO2 (Lmin-1) values 
were averaged over the last 15 min of gas collection and used to determine the rates of fat and 
carbohydrate oxidation.  Resting metabolic rate (RMR) was estimated using total VO2 (Lmin-1) 
over the final 15 min and an assumed relationship of 5 kcal per litre of O2.  The following 
stoichiometric equations were used with the assumption that protein oxidation was negligible 
(53): 
Fat oxidation (g/min) = 1.695 · VO2 (Lmin-1) · 1.701 · VCO2 (Lmin-1) 
Carbohydrate oxidation (g/min) = 4.210 · VCO2 (Lmin-1) · 2.962 ·VO2 (Lmin-1) 
 
 
Appetite Perceptions.	  Participants recorded perceptions of hunger, fullness, satisfaction, and 
prospective EI using VAS (54).  Responses were recorded upon arriving at lab (fasting) and 
immediately before every blood draw.  The VAS involved marking along a 100 mm line in 
response to questions such as: “ How often do you eat breakfast in the morning?”; “How hungry 
do you feel right now?”; “How full do you feel right now?”; “How satisfied do you feel right 
now?”; and “How much food could you eat right now?”.  The assessment of these questions 
utilizing VAS has been validated (54) and used in past appetite research (55).  
Blood Sampling.	 	Two 3-mL	venous blood samples were collected from an antecubital vein at 
0845 h (#1; fasting), 0930 (#2; 30 min post-prandial), 1000 (#3; 60 min post-prandial), and 1030 
h (#4; 90 min post-prandial) while participants were in the supine position.  Blood samples were 
collected into pre-chilled vacutainer tubes (BD vacutainer K2 ethylenediaminetetraacetic acid 
[EDTA; lavender top]; Becton, Dickinson and Company, NJ, USA).  Inhibitors were 
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immediately added for hormone preservation.  To preserve AG, 4-(2-Aminoethyl) 
benzenesulfonyl fluoride hydrochloride was added (AEBSF; 10 µL per 1 mL of whole blood) to 
the first vacutainer tube.  To prevent inactivation of GLP-1, 10-µL of DPP-IV inhibitor and 500 
KIU aprotinin per mL whole blood was added to the second vacutainer tube.  Estradiol and 
progesterone samples were analyzed from samples containing AEBSF, similar to past reports 
(56-58).  
All tubes were gently inverted ~10 times and centrifuged at 3000 rpm for 10 min at 4°C.  
The plasma supernatant was then aliquoted into microcentrifuge tubes.   To preserve AG, plasma 
was acidified by the addition of 100 µL of 1 M HCl per mL plasma (50 µL).  All samples were 
stored at -80°C for subsequent analysis. 
Biochemical Analysis.	 	Commercially available enzyme-linked immunosorbent assays (ELISA) 
were performed according to manufacturer recommendations to determine plasma concentrations 
of AG (Cat. # EZGRA-88K, EMD Millipore, MA, USA), active GLP-1 (Cat. # EGLP-35K, EMD 
Millipore, MA, USA), E2 (SKU: DCM003, Eagle Biosciencesm, Inc., NH, USA), and P4 (SKU: 
DCM025, Eagle Biosciencesm, Inc., NH, USA).  The acylated ghrelin assay was specific for 
measuring the active (acylated) form of this peptide in human serum or plasma with no cross 
reactivity with inactive (des-acyl) ghrelin.  The active GLP-1 assay was specific for measuring 
the two active forms of this peptide (GLP-17-36 and GLP-17-37) in human plasma with no cross 
reactivity (<3%) with other forms of GLP-1 (i.e. GLP-11-36, GLP-11-37, GLP-19-36, GLP-19-37).  
Estradiol assay had no cross reactivity (<2%) with other forms of estrogen and the progesterone 
assay did not cross react with testosterone (<1%) or other progesterones (<1%).   To eliminate 
inter-assay variation, samples from each participant were analyzed in the same run.  Samples 
were run in duplicate to reduce intra-assay variation.  The intra-assay coefficient of variation was 
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8.41±5.66 for AG, 11.07±8.29 for active GLP-1, 6.01±5.82 for E2, and 5.16±5.93 for P4; all were 
below the accepted standard of detection for each kit.  
Statistical analysis.		Data were analyzed using SPSS software version 22.0 for Windows (SPSS, 
Chicago, IL).  One-way repeated measures ANOVA were used to compare body weight, fat and 
carbohydrate oxidation, resting metabolic rate, and respiratory exchange ratio (RER) across 
menstrual phases.  One-way repeated measures ANOVA were performed to compare fasting AG 
and active GLP-1 concentrations across menstrual phases.  To calculate the relative change in 
hormones, data were normalized to baseline values and analyzed as change from fasting.  To 
compare the changes of AG and active GLP-1, 4 x 3 repeated measures ANOVA (time x phase) 
were performed.  Absolute AG and GLP-1 concentrations were also analyzed but the same 
results were found so for clarity only relative change data will be reported.  Hormone 
concentrations were used to calculate area under the curve (AUC) using the trapezoidal method 
(59) and these AUC values were compared using one-way ANOVA across menstrual phases.  
Perceptions of appetite were also normalized to baseline and analyzed with 4 x 3 repeated 
measures ANOVA (time x phase).  All tests were performed separately on oral-contraceptive 
users and naturally cycling females and similar trends were observed.  Where significant main 
effects were found, post-hoc analysis using a Bonferroni correction for multiple comparisons 
was performed.  Statistical significance was set to p < 0.05.  All data are presented as 
mean±standard deviation. 
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Results 
Participants.	 	Participant body weight did not change (P=0.249) across menstrual phases (Table 
1).  Participants all reported regularly eating breakfast in the mornings (80±9 mm) and 
successfully replicated energy intake the day before all sessions (FP: 1442.8±540.7 kcal, OP: 
1492.8±671.15, LP: 1582.6±314.7).  Three participants were currently using tri-phasic oral 
contraception (Tri-cyclen lo, Janssen Pharmaceuticals, ONT, Canada) for >1 y and maintained 
usage throughout the study while the other 5 participants had not been using any form of 
hormonal birth control for >1 y prior to participation.  
 
 
 
 
 
 
 
 
 
 Body temperature indicated that ovulation had occurred in the non-contraception using 
females prior to the LP session (Table 1); body temperature was significantly elevated during the 
LP compared to FP (P=0.030) and OP (P=0.034).  Moreover, fasting plasma E2 and P4 
concentrations (Table 1) confirm proper timing of testing sessions and are in accordance with 
accepted concentrations for E2 and P4 during all menstrual phases (Eagle Biosciences, Inc., NH, 
USA).  E2 was elevated during the OP compared to both the FP (P=0.003) and LP (P=0.024); E2 
Table 1: Participant characteristics. Note: unlike letters represent 
significant differences (P<0.05).  
  Follicular  
Phase 
Ovulatory 
Phase 
Luteal  
Phase 
Session day 4.0±1.0 9.4±1.1 23.2±1.6 
Body weight (kg) 63.9±15.3a 63.3±14.5a 63.4±15.2a 
Body temperature (°C) 36.2±0.1a 36.2±0.1a 36.7±0.1b 
E2 (pgmL-1) 26.92±15.58a 180.26±53.07b 98.08±17.67c 
P4 (NgmL-1) 1.39±1.48a 0.90±0.50a 43.05±14.79b 
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was also elevated in the LP compared to the FP (P=0.001).  P4 was elevated during the LP 
compared to both the FP (P=0.004) and OP (P=0.005); P4 was similar during the FP and OP 
(P=0.306). 
Appetite-Regulating Hormones.	 	There was no difference in the fasting concentrations of AG 
across the menstrual phases (P=0.848, ηp2=0.023).  There was no effect of menstrual cycle phase 
(P=0.959, ηp2=0.006) or phase x time interaction (P=0.433, ηp2=0.126) on the post-prandial 
change in AG.  There was a main effect of time (P=0.008, ηp2=0.424) such that AG 
concentrations were decreased 30 (P=0.042), 60 (P=0.014), and 90 min post-prandially 
(P=0.034) compared to fasting (Figure 1).  There was no difference (P=0.185, ηp2=0.214) in the 
AG AUC.  
 
 
Figure 1: (A) Relative change from baseline and (B) AUC of AG during each menstrual 
phase. No significant differences were found between phases. Note: * - indicates significantly 
lower relative to fasting (P=0.008); AG – acylated ghrelin; AUC – area under the curve. All 
data presented as mean±SD. 
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 There was no difference in the fasting concentrations of active GLP-1 across the 
menstrual phases (P=0.567, ηp2=0.051).  There was no effect of menstrual cycle phase on the 
relative change in active GLP-1 from fasting (P=0.650, ηp2=0.06) or a phase x time interaction 
(P=0.398, ηp2=0.069).  There was a main effect of time (P=0.027, ηp2=0.483) where active GLP-
1 was elevated 30 (P=0.021) and 60 min post-prandially (P=0.043), but not 90 min post-
prandially (P=0.051) compared to fasting (Figure 2).  There was no difference (P=0.605, ηp2=0.069) in active GLP-1 AUC.  
Appetite Perceptions.	 	There was no effect of menstrual cycle phase (P=0.263, ηp2=0.174) or 
phase x time interaction (P=0.241, ηp2=0.179) on perceptions of hunger but there was a main 
effect of time (P=0.001, ηp2=0.660) (Figure 3A).  Perceived hunger was lower 30 (P=0.001), 60 
(P=0.002), and 90 min post-prandially (P=0.012) compared to fasting.  There was a main effect 
of phase (P=0.048, ηp2=0.351) and time on perceived fullness (P<0.001, ηp2=0.693), but no 
phase x time interaction (P=0.1, ηp2=0.262).  The main effect of phase showed that fullness was 
Figure 2: (A) Relative change from baseline and (B) AUC of active GLP-1 during each 
menstrual phase. No significant differences were found between phases. Note: * - 
indicates significantly elevated relative to fasting (P=0.027); AG – acylated ghrelin; AUC 
– area under the curve. All data presented as mean±SD.   
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greater during the OP compared to the FP (P=0.02) and approached significance in the LP 
(P=0.06).  The main effect of time showed that fullness was greater 30 (P<0.001), 60 (P=0.001), 
and 90 min post-prandially (P=0.009) compared to fasting (Figure 3B).  For satisfaction there 
was a main effect of time (P<0.001, ηp2=0.784) but no effect of phase (P=0.263, ηp2=0.174) or 
phase x time interaction (P=0.235, ηp2=0.167).  Satisfaction was increased 30 (P<0.001), 60 
(P=0.001), and 90 min post-prandially (P=0.002) compared to fasting (Figure 3C).   
 
 
Figure 3: Changes in (A) perceived hunger, (B) satisfaction, (C) fullness, and (D) prospective 
energy intake during each menstrual phase. Note: * - indicates significantly different than 
fasting (P<0.05). All data presented as mean±SD.	
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For prospective energy intake, there was no effect of menstrual cycle phase (P=0.725, ηp2=0.045) 
or phase x time interaction (P=0.110, ηp2=0.210) but there was a main effect of time (P<0.001, ηp2=0.705) (Figure 3D).  Prospective energy intake was decreased 30 (P<0.001), 60 (P=0.001), 
and 90 min post-prandially (P=0.002) compared to fasting (Figure 3D).  There was no difference 
in anxiety or nausea between phases (P>0.05; data not shown).  
 
 
Resting Metabolic Rate, RER, and Substrate Oxidation.		There was no effect of menstrual cycle 
phase on resting metabolic rate (P=0.961, ηp2=0.006), RER (P=0.399, ηp2=0.123), carbohydrate 
oxidation rate (P=0.603, ηp2=0.07), or fat oxidation rate (P=0.485, ηp2=0.098) (Table 2). 
 
Discussion 
 The present study was designed to explore the effect of female menstrual cycle phase on 
appetite-regulating hormones, resting metabolic rate, and perceptions of appetite.  We 
hypothesized that appetite-regulating hormones and perceived appetite would fluctuate 
throughout the menstrual cycle in conjunction with female sex hormones.  The main findings of 
this project are: (a) menstrual cycle phase had no effect on AG or active GLP-1, (b) post-prandial 
Table 2: Resting metabolic rate, RER, and substrate oxidation.  No significant differences were found. 
 Follicular Phase Ovulatory Phase Luteal Phase 
Resting metabolic rate (kcal) 1381±297 1399±330 1421±378 
Respiratory exchange ratio 0.92±0.07 0.88±0.04 0.91±0.04 
Carbohydrate oxidation (gmin-1) 0.17±0.05 0.14±0.04 0.16±0.04 
Fat oxidation (gmin-1) 0.03±0.03 0.04±0.02 0.03±0.02 
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fullness was greatest during the OP, and (c) resting metabolic rate and substrate oxidation were 
unaffected by menstrual phase.  These results indicate that AG and GLP-1 are not responsible for 
changes in energy intake across the menstrual cycle. 
 We did not observe any effect of menstrual cycle phase on the concentrations of AG, 
similar to past reports (57,58,60).  Estradiol is believed to reduce energy intake by reducing the 
quantity of food consumed at each meal (13,61), suggesting that the post-prandial hormonal 
response to energy intake would be different in conjunction with varying E2 concentrations (e.g. 
a more profound decrease in post-prandial AG during the OP, thereby reducing hunger and 
energy intake, compared to the LP).  We are the first to measure the post-prandial change in AG 
across the menstrual cycle and our data do not support this idea, nor are what would be expected 
when considering the consistent fluctuations in energy intake across the menstrual cycle (9-12).  
Therefore, our data extend on past work to show that fluctuations in sex hormones across a 
typical menstrual cycle do not affect AG or the post-prandial change in AG. 
Similar to AG, there was no difference in active GLP-1 across menstrual phases.  Only 
one other report has examined the effect of menstrual phase on GLP-1 and found that total GLP-
1 concentrations were lower in the FP compared to the LP because of slowed gastric emptying 
during the FP (24).  In contrast, our current results found no differences in the active form of 
GLP-1, suggesting that active and total forms of GLP-1 might be differently affected by female 
sex hormones.  However, our data suggest that active GLP-1 is unlikely to be altered by 
menstrual phase or female sex hormones and therefore unlikely to explain the previously 
observed changes in energy intake.  
Interestingly, we did find that perceived fullness was greater during the OP compared to 
LP, although perceived hunger and prospective energy intake were similar.  These findings could 
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be produced by the elevated E2 concentrations observed during the OP phase and would be in 
line with the reduced energy intake from past literature. (10,11,44).  Additionally, although 
statistically insignificant, 30 min post-prandial hunger appeared to be reduced to a greater extent 
during OP (-50%) compared to both the FP (-27%) and LP (-33%).  To our knowledge this is the 
first study to investigate these perceptions across the menstrual cycle.  Our similar hormonal 
profiles in conjunction with the different perceptions of appetite imply that central mechanisms 
could account for the changing energy intake across the menstrual cycle.  Perhaps E2 and P4 
influence neuronal control of energy intake within the arcuate nucleus (ARC) such that similar 
hormonal concentrations lead to different perceptions of appetite.  But given that perceived 
hunger and fullness correlate with actual energy intake (31) the current differences warrant 
future investigation.  
In light of the current data, it seems that production of AG and active GLP-1 are not 
responsible for the changes in energy intake that occur throughout the menstrual cycle.  Indeed, 
our work supports that the sensitivity to these hormones is changing, as has been demonstrated 
for other appetite-regulating hormones, such as cholecystokinin (19), total ghrelin (7), and leptin 
(62,63).  Sensitivity to gut hormones would likely occur within the ARC as it is responsible for 
integrating hormonal signals to control energy intake (27). Both NPY/AgRP and POMC/CART 
neurons within the ARC possess abundant E2 receptors (62-65).  Similarly, prolonged (28 d) P4 
treatment up-regulated NPY and down-regulated CART genes (both of which would be expected 
to stimulate EI) (66).  Altered sensitivity would explain why we found similar circulating 
hormone concentrations but different perceptions of fullness across menstrual phases. 
Finally, we observed no difference in substrate oxidation or RMR across menstrual 
phases.  While previous studies demonstrated a slightly elevated RMR during the LP phase (39-
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43), the present data illustrates no differences across phase.  However, RMR can be increased 
from 2.5-11.5% during the LP compared to the FP, and the current data is within this range, 
despite being statistically insignificant.  Similarly, fat oxidation rate was increased during the OP 
(0.04 gmin-1) compared to the FP and LP (both 0.028 gmin-1) as we would expect when E2 
concentrations are elevated (67), although this was also statistically insignificant.  Our small 
sample size likely contributes to our inability to detect the small differences that occur across 
menstrual phases.  
 An important limitation to the current project is that we had participants arrive at 0800 
and assessed appetite-regulating hormones over ~2.5 h although there are circadian rhythms 
associated with female sex hormones.  Specifically, P4 concentrations decrease throughout the 
day and E2 concentrations might decrease post-prandially (68) meaning we may have missed 
peaks or nadirs in female sex hormones.  Future work should extend on the current project by 
measuring at different times of day and sampling hormones over longer fasting and post-prandial 
time periods.  Moreover, we fed participants identical test meals (29 kJkg-1 body weight).  
Considering the amount consumed at each meals is responsible for the changes in energy intake 
observed throughout the menstrual cycle (44) further research should test post-prandial hormonal 
responses to meals of various caloric content and even macronutrient composition.  Additionally, 
we measured only two appetite-regulating hormones, but there is evidence that others could be 
important, including cholecystokinin (69), leptin (18), and insulin (15).  We also had a relatively 
small sample size and all females were young and normal weight.  We intentionally collected on 
normal-weight females as body composition can attenuate the post-prandial rise in GLP-1 and 
fall ghrelin (70).  In light of the particular challenge overweight females have with managing 
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body weight and their propensity to progress into obesity future research will need to confirm the 
present findings in overweight and obese females. 
Conclusion 
The current project was designed to test the effects of female menstrual cycle phase on 
appetite-regulating hormones and perceived appetite.  We show that fasting and post-prandial 
AG and active GLP-1 are unaffected by female menstrual cycle phase.  Given the difficulty 
females experience with weight management it is important to continue exploring potential 
mechanisms of appetite and energy intake regulation.  In light of accumulating research, future 
work should investigate the effects of menstrual cycle phase on neuronal control of appetite and 
energy intake and their sensitivity to circulating hormones since we show that gut-derived 
hormones are unaffected.   
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 The current project was designed to examine whether the changes in estradiol and 
progesterone across the menstrual cycle are related to changes in appetite-regulating hormones 
and perceptions of appetite.  Our results demonstrate that menstrual cycle phase has no effect on 
AG or active GLP-1 but fullness was greatest during the OP.  These data show that the 
concentrations AG and active GLP-1 are not responsible for the fluctuating energy intake across 
the menstrual cycle and suggest other mechanisms are affecting appetite.  
We did not observe any effect of menstrual cycle phase on the concentrations of AG, 
similar to past reports (1-3).  Importantly the circulating concentrations in the current project are 
similar to those reported in other studies (4-6).  In light of previous research showing that 
estradiol can influence the production of ghrelin it is possible that the estradiol fluctuations 
across a normal menstrual cycle are not great enough to affect ghrelin production.  Indeed, the 
human study showing that estradiol affects ghrelin production was in amenorrheic females who 
express diminished estradiol and progesterone concentrations (7) making it difficult to 
extrapolate the results to a healthy eumenorrheic population.  Based on the current AG data, to 
detect a 20% difference in AG with 80% power, we would require 152 participants, reflecting 
that any potential difference is small and unlikely to explain the changing energy intake.  Finally, 
we performed Pearson correlations between fasting AG and estradiol concentrations to see if we 
missed any possible relationships.  The only significant relationship was an inverse correlation 
between AG and estradiol during the LP (r=-0.764, P=0.027).  This result is interesting but 
difficult to reconcile with the other results showing that AG concentrations did not differ across 
menstrual phases.  There were no significant correlations between progesterone and AG.  We 
found moderate correlations between AG and perceptions of hunger at 30 (r=0.584, P=0.003), 60 
(r=0.481, P=0.021), and 90 min post-prandially (r=0.647, P=0.001), as would be expected based 
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off of past literature (8).  Our current results support previous work demonstrating that sex 
hormone fluctuations across the menstrual cycle do not affect ghrelin making it unlikely to 
explain the changes in energy intake.  
Only one previous study examined the effect of menstrual phase on GLP-1 and found that 
total GLP-1 concentrations were lower in the FP compared to the LP (9). Contrary to this we 
found no difference in the active forms of GLP-1.  The reasons for our conflicting results are 
unclear, but participants in the previous study were fed only 50 g glucose dissolved in 300 mL 
water (200 kcal) (9).  Importantly, GLP-1 has important incretin effects, specifically inducing 
insulin secretion and glucose uptake by skeletal muscle and adipose tissue (10).  Thus, a dose of 
glucose compared to a meal replacement, as in the current report, with ~0.2 g/kg of fat and ~0.5 
g/kg protein content, might be expected to produce a different incretin hormonal response due to 
slower digestion and lower glycemic load.  With the current GLP-1 data, to detect a 20% 
difference in active GLP-1 with 80% power, we would require 30 participants, suggesting that 
any difference is quite small.  The current concentrations of active GLP-1 are slightly greater 
than that previously observed (11) but very few studies have examined this form of GLP-1.  
When we performed correlations between estradiol and active GLP-1, we observed significant 
correlations during the OP (r=0.752, P=0.031), LP (r=0.816, P=0.013), and approached 
significance during the FP (r=0.696, P=0.055). We found no significant correlations between 
GLP-1 and progesterone.  We observed no significant correlations between active GLP-1 and 
perceptions of fullness.  However, a past study found that GLP-1 only correlated with fullness 
during the late phase of satiety (60-180 min post-prandial), thus our more acute study might miss 
this relationship. Taken together, we show that active GLP-1 is unaffected by menstrual phase. 
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The only observed difference in the current report is that post-prandial fullness was 
greater during the OP compared to FP and approached significance in the LP.  This result is 
interesting given that females consume less food during the OP (12).  Importantly, this occurred 
in conjunction with increased estradiol concentrations, reflecting estradiol’s anorexigenic 
properties (13,14).  At the same time, although it was statistically insignificant, post-prandial 
hunger appeared to be suppressed to a greater extent during the OP compared to both the FP and 
LP.  This result makes sense given the greater fullness, but nevertheless aligns with our 
hypothesis.  However, there was no correlation between fasting estradiol concentrations and 
perceptions of hunger (r=-0.198, P=0.353) or fullness (r=-0.05, P=0.816).  We saw no 
differences between perceptions of appetite during the LP, implying that progesterone is not 
producing an orexigenic effect during this phase.  This was supported by no apparent 
correlations between progesterone and fasting hunger (r=0.046, P=0.832) or fullness (r=0.165, 
P=0.441).  AG and GLP-1 concentrations were similar meaning these cannot explain the altered 
appetite we observed during the OP.  However, altered sensitivity to appetite-regulating 
hormones, other appetite-regulating hormones such as CCK and leptin, or the circadian rhythms 
of estradiol and progesterone could all be contributing the current results. 
 The current report did not observe any difference in energy intake, as assessed by self-
report food logs, across the menstrual cycle.  When assessed as absolute kcal there was no 
difference in the average 48 h energy intake across sessions (P=0.850, ηp2=0.010) (Table 2).  We 
also found no difference in the consumption (grams) of protein (P=0.51, ηp2=0.048), fat (0.357, ηp2=0.071), or carbohydrate (0.283, ηp2=0.086) (Table 2).  When analyzed as kcal/kg body 
weight the same results were observed.  This is opposed to numerous reports (12,15-17) 
demonstrating that energy intake increases by up to 90-500 kcal/day, or an increment of 3.9-
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34.7%, during the LP compared to the FP (18).  Although this difference is certainly capable of 
altering energy balance and body weight, it is a relatively small change to try and detect with 
food logs.  People regularly underreport energy intake by ~25-50% (19) making it unsurprising 
that we were unable to detect a change that may be as little as 3%.  Unfortunately, adherence to 
food reporting was poor (only 4 of 8 participants completed all 3 phases) and there was evidence 
of under reporting for the current report forcing us to remove this data from the manuscript.  This 
is not uncommon as up to 72% of females underreport food intake (20,21) by as much as ~25% 
(20,21,22).  Fluctuations in energy intake during the menstrual cycle are generally accepted so 
our current results are very likely due to our collection methods.   
We did not detect any differences in resting metabolic rate or substrate oxidation despite 
numerous past reports demonstrating significant differences in energy expenditure across the 
menstrual cycle (23-25).  Although the reason for this is unclear, our small sample size could 
contribute.  As previously mentioned, the differences detected are generally quite small, ~8% 
(23), and are detected over long periods of time.  Considering the current data (0.94±0.19 
kcal/min), to detect an 8% difference in energy expenditure with 80% power, we would require 
204 participants, affirming the small differences that exist across menstrual phases.  However, 
because energy expenditure and energy deficits are important factors in the regulation of 
appetite-regulating hormones and perceived appetite (11,26), the current data does allow us to 
say that energy expenditure was not a confounding factor for hormonal concentrations or 
perceptions of appetite in the current report.   
Limitations and Future Directions.  It is important to recognize that this project explored only a 
small set of appetite-regulating hormones and that estradiol can influence other appetite-
regulating hormones, such as CCK, leptin, and insulin.  CCK is a satiety-inducing hormone and 
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there is evidence that estradiol increases its potency (14).  It is not clear exactly how estradiol 
enhances the potency of CCK, but there is a site of interaction within the hypothalamus so it is 
possible that ARC neurons play a role (27).  At the same time, leptin and insulin are important 
signals capable of reducing energy intake and are both influenced by estradiol (28).  Much like 
CCK, the anorexigenic effect of leptin appears to be enhanced in the presence of estradiol.  
Eating was reduced more substantially in female rats compared to males when leptin was infused 
directly into their brains, an effect that was attributed to the anorexigenic potency of leptin being 
enhanced by estradiol (29).  A potential mechanism for this is again the colocalization of leptin 
and estradiol receptors on NPY/AgRP and POMC/CART neurons (30).  Finally, there are 
important sites of interaction between estradiol and insulin, including on NPY/AgRP and POMC 
neurons (31).  Therefore, future projects will need to consider all of these possible interactions 
and test concentrations of hormones and neuropeptides across menstrual phases before we can 
conclusively say why energy intake consistently changes.  
In light of the current data, it seems that the gut-derived hormones AG and active GLP-1 
are not responsible for the changes in energy intake that occur throughout the menstrual cycle.  
However, changing sensitivity to these hormones still remains a viable explanation (29,32-34).  
Altered sensitivity to gut hormones likely occurs in the ARC given that both NPY/AgRP and 
POMC/CART neurons possess abundant E2 receptors.  Thus, E2 might exerts it anorexigenic 
effect directly on the neurons that regulate energy intake (13,33,35,36).  At the same time, up-
regulated NPY and down-regulated CART genes (both of which would be expected to stimulate 
EI) were observed when female rats were treated with progesterone for 28 days (37).  Taken 
together, these data implicate the ARC in the modulation of energy intake in response to 
fluctuations in female sex hormones throughout the menstrual cycle. 
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 Historically the ARC was thought to be the key site for regulating energy intake, but it is 
now recognized that a broader neural network, including the fusiform, amygdala, hippocampus, 
and dorsal striatum contributes to the regulation of energy intake (32).  Research is beginning to 
use brain-imaging techniques (e.g. fMRI) to explore how different brain regions respond to food 
intake or food images and has produced interesting results that are relevant to the current project.  
For instance, food images produced greater activation of lateral and dorsolateral prefrontal 
cortex, and parietal cortex in females compared to males (38).  Moreover, food pictures 
activated the lateral orbitofrontal cortex, prefrontal cortex, hippocampus, amygdala, and fusiform 
of females scanned around ovulation, whereas only the fusiform was activated in the LP (32).  
These results likely reflect that numerous brain regions possess estrogen receptors (39) which 
could make them susceptible to the fluctuations in female sex hormones associated with the 
menstrual cycle.  Taken together, these data suggest that the effects of female sex hormones are 
highly complex and can influence appetite and energy intake through various central 
mechanisms.   
 One important factor that must be addressed in future research on the menstrual cycle is 
how to accurately and easily monitor menstrual phase.  A recent report used ultrasound scans of 
participants’ ovaries every morning over a one month study (1) thereby affording great accuracy 
but high burden on researchers and participants.  The current project used a combination of body 
temperature, similar to other reports (40,41), and predicted menstrual cycle days based off of 
menstrual history.  Although this is a convenient method, the pre-ovulatory estradiol surge is 
particularly difficult to monitor and predict.  Even the use of ovulation kits would not have been 
helpful as those measure the estradiol-induced surge in luteinizing hormone.  Indeed, the 
menstrual cycle is inconsistent and can be perturbed by many factors (e.g. stress and exercise) 
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making it difficult to predict.  Furthermore, up to 12% of menstrual cycles can be anovulatory in 
young healthy females (42).  Anovulatory cycles are asymptomatic and produce diminished 
concentrations of both estradiol and progesterone during the LP (42) which will distort the 
conclusions of research on the menstrual cycle.  Finally, although the current project divided the 
menstrual cycle into three phases, it is possible to do this differently.  For instance, others divide 
it simply into pre- and post-menstrual phases (12) or into early follicular (days 1–4), late 
follicular (days 5–11), periovulation (days 12–15) and the luteal phase (days 16–28) (18).  
Together these issues exacerbate the complexity of conducting research on female physiology, 
especially research on the menstrual cycle. 
 Another potential confounding factor is our use of participants using tri-phasic hormonal 
contraceptives.  Tri-phasic pills suppress endogenous hormone production (43) as can be 
observed by the low concentrations of estradiol and progesterone in the three participants using 
pills during the current project (see Appendix VI).  However, tri-phasic pills, such as the one 
used by our participants, contain changing doses of an estrogen and progesterone and, so long as 
pills are taken as directed, produce a hormonal environment similar to a normal menstrual cycle 
(43).  Indeed, authors of this study concluded that tri-phasic pills represent an ideal research tool 
for investigating the effects of ovarian hormones (43).  To confirm that the current results were 
the same in non-oral contraceptive using participants we performed a 4 x 3 ANOVA (time x 
phase) on the relative chance in AG and active GLP-1 in only these five participants.  As 
expected, there was no effect of phase or phase by time interaction on AG (P=0.659 ηp2=0.055, 
P=0.835 ηp2=0.102, respectively) or active GLP-1 (P=0.313 ηp2=0.252, P=0.547 ηp2=0.175, 
respectively).   Therefore, it is unlikely that the inclusion of participants using tri-phasic 
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contraception skewed our data and suggests that it could be beneficial for future research to 
include only tri-phasic pill users to monitor menstrual phase.  
Conclusions.  Until 1993, when the NIH mandated the inclusion of females in clinical research, 
most physiological research had been performed on males (44).  Until this time, the primary 
function of female sex hormones was believed to be the creation of a hospitable environment for 
conception and fetal development (44).  Gradually, it is becoming clear that females require 
unique research.  This seems logical given that females experience unique hormonal fluctuations 
that likely have important physiological effects.  Despite research beginning to appreciate the 
numerous functions of female sex hormones, when reviewing literature on the effects of exercise 
on appetite-regulating hormones there are 43 studies that looked at only male participants, 12 
studies included males and females, five were females only, but of all the studies on females, 
only two controlled for menstrual phase; although they were only during early FP when both 
estradiol and progesterone are at their lowest concentrations (4,45).  Together, these 
considerations make it important that research such as the current project continue to be 
performed.  
 We chose to focus on appetite-regulation given the changes in cravings and energy intake 
across the menstrual cycle (12,46). Ultimately, females are probably in a battle against biology 
and evolution.  Given that small energy deficits can have detrimental effects on reproductive 
health and that females require a relatively high percentage of body fat to experience regular 
menstrual cycles, it is conceivable that numerous redundant mechanisms exist to ensure that 
females tightly maintain fat stores and energy intake.  Indeed, central (e.g. various brain regions) 
and peripheral (e.g. numerous appetite-regulating hormones) mechanisms likely all contribute to 
the regulation of energy intake in females.  The current report found that two gut-derived 
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hormones (AG and active GLP-1) are not responsible for the difference in energy intake across 
the menstrual cycle but we did find that perceptions of appetite differ across menstrual phases.  
We have proposed other mechanisms that warrant investigation to eventually contribute to our 
understanding of female weight management.  
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Appendix I – Visual Analogue Scale	
 
	Participant	Code:	________________________	
	
	Date:	_____________	 	 	
	
	 	 	 	Session:	__________________________________		
	
	
	
Question	1:	How	often	do	you	eat	breakfast	in	the	morning?	
	 	 	 															
	
___________________________________________	
	
Question	2:	How	hungry	are	you	right	now?	
	
	
	 														___________________________________________	
	
Question	3:	How	full	do	you	feel	right	now?		
	
	
	 														___________________________________________	
	
Question	4:	How	much	do	you	think	you	could	eat	right	now?	
	
	 	 	 	 	
	 														___________________________________________	
Not	hungry	at	all	 Very	hungry	
Not	full	at	all	
Very	full	
Nothing	at	all	 A	lot		
Every	morning	Never	
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Question	5:	How	anxious	are	you	right	now?		
	
	
	 														___________________________________________	
	 	
Question	6:	How	nauseated	are	you	right	now?	
	
	
	 														___________________________________________	
	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Not	anxious	at	all	 Very	anxious	
Very	nauseated	Not	nauseated	at	all	
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Appendix II – Daily Food Log 
Instructions: 
 
1. Record all food intake for a 3 day period (day before session, day of session, day after 
session) 
2. Try to consume foods that you would typically eat as part of your regular diet.  
3. Keep your recording sheets with you at all times. (Snacks are typically consumed 
unpredictably and, as a result, it is impossible to record them accurately unless your 
recording forms are nearby.) 
4. Use a small food scale if you have one or standard-measuring devices (measuring cups, 
measuring spoons, etc) to record the quantities consumed, as accurately as possible. If 
you do not eat all of the item re-measure what’s left and record the difference. 
5. Record combination foods separately (i.e., hot dog, bun, and condiments) and include 
brand names of food items (list contents of homemade items) whenever possible. 
6. For packaged items, use labels to determine quantities. 
 
 
Example: 
 
Time of Day 
(i.e. 8:15 am, 
12:30 pm) 
Food Item (include 
brand name if 
possible) 
Quantity 
(i.e. g, mL, 
cups, etc.) 
Notes 
(i.e. ingredients & 
amounts used if 
possible) 
9:30 am Eggs 
 
2 whole 
 
½ tsp salt, ½ cup 
cheese, ½ tsp butter 
9:30 am Egg whites ½ cup - 
10:15 am Tropicana orange juice 1 cup - 
11:05 am Apple 1 whole - 
1:50 pm Dominos Pizza 4 slices Pepperoni, mushroom, 
cheese 
1:50 pm Pepsi 500 ml - 
 
 
66	
	
DAY 1 (day before session)     Date: ___________  
 
Time of Day 
(i.e. 8:15 am, 
12:30 pm) 
Food Item  
(Include brand name if 
possible) 
Quantity 
(i.e. g, mL, 
cups, etc.) 
Notes 
(i.e. ingredients & 
amounts used if 
possible) 
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Appendix III – Study Recruitment Poster 
FEMALES NEEDED FOR 
APPETITE REGULATION 
STUDY  
(REB #4598)	 
 
What is Appetite Regulation? 
Ø Various hormones control how much we eat 
Ø The female menstrual cycle may alter these hormones 
 
Purpose:  
Determine whether the hormones associated with the menstrual cycle alters the 
hormones that control food intake 
 
Study details: 
Ø Each session involves 4 blood samples taken from the arm  
 
Ø In order to participate you must be: 
o Female, 18-35 years of age 
o Regularly menstruating 
o Non-hormonal contraceptive user (or using tri-phasic pill, such as: Ortho 
Tri-Cyclen, Enpresse, and Ortho-Novum 7/7/7) 
o Healthy  and exercise ≤3 per week 
o Non-smoker 
 
Ø Time commitment:  
o 3 sessions of ~3 h (9 hrs total) 
o Sessions will be over 1 menstrual cycle (~1 month) 
 
Benefits of participating: 
Ø Learn and contribute to the better understanding of female physiology 
Ø Three free meals! 
If interested please contact: 
Logan Townsend, M.Sc. student – town9000@mylaurier.ca 
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Appendix IV – Ethics 
 
	
	
	
CONSENT	TO	PARTICIPATE	IN	RESEARCH	
LETTER	OF	INFORMATION	
	
Date:		
Title	of	Study:	The	Effect	of	Menstrual	Phase	on	Energy	Regulating	Hormones	in	Response	to	Sprint-
Interval	Training	(REB	#4598)	
	
Dear	______________________________:	
You	are	being	invited	to	participate	in	a	research	study	conducted	by	Tom	J.	Hazell	(PhD),	Hashim	Islam	
(BSc	Kin),	and	Logan	Townsend	(BA	Kin)	from	the	Energy	Metabolism	Research	Laboratory.	
In	order	to	participate	it	is	important	you	are:	a)	between	18-30	year	old,	b)	recreationally	active	<3/wk,	
c)	healthy,	d)	normally	menstruating,	e)	either	using	no	form	of	hormonal	contraceptive	or	using	a	tri-
phasic	pill	as	this	project	is	designed	to	determine	how	these	hormones	influence	appetite	hormones.		
PURPOSE	OF	THE	STUDY	
The	primary	purpose	of	 this	study	 is	 to	examine	the	effects	of	acute	sprint	 interval	 training	on	energy	
expenditure	and	hormones	that	regulate	 	energy	intake		 in	women	and	how	the	menstrual	phase	may	
influence	this	in	order	to	determine	potential	fat	loss	mechanisms.	
PROCEDURES	
This	study	requires	you	to	visit	the	Energy	Metabolism	Research	Laboratory	3	separate	times,	one	for	a	
familiarization	session	(<30	min)	and	then	for	2	testing	sessions	(~4.5	h)	for	a	total	time	commitment	of	
~9	hours.		All	experimental	sessions	(separated	by	96	h)	will	include	a	standardized	breakfast	and	30	min	
exercise	 session	 (7	min	warm-up,	 18	min	 SIT	 exercise,	 and	 5	min	 cool-down)	 followed	by	 a	 3	 h	 post-
exercise	measure	of	gas	exchange	where	participants	rest	comfortably	and	quietly	in	the	laboratory	(i.e.	
reading).	Blood	samples	will	also	be	drawn	from	the	forearm	pre-	and	post-exercise	 (4	samples	total).	
Blood	draws	will	be	taken	from	the	inner	elbow	while	seated	by	a	trained	researcher;	all	equipment	will	
be	sterile	one-time	use.	Blood	draw	site	will	be	cleaned	prior	to	each	sample	and	researcher	will	wear	
clean	gloves	to	ensure	cleanliness.	The	exercise	will	involve	traditional	SIT	characterized	by	4	bouts	of	30	
sec	 "all-out"	 efforts	 followed	 by	 4	 min	 rest/active	 recovery	 (i.e.	 light	 walking).	 The	 exercise	 session	
includes	only	2	min	of	work	and	16	min	of	rest/recovery.		You	will	also	be	asked	several	questions	before	
and	after	exercise	to	determine	your	feelings	of	hunger	and	satiety.	You	will	be	asked	to	record	dietary	
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intake	the	day	before	the	trail,	on	trial	day	and	the	day	after.	You	will	also	be	required	to	give	a	detailed	
history	of	your	menstrual	cycle,	including	length	of	recent	cycles,	when	you	began	menstruating,	and	if	
you	have	ever	had	irregular	menstrual	cycles.		
POTENTIAL	RISKS	AND	DISCOMFORTS	
We	appreciated	that	this	study	requires	you	to	discuss	highly	personal	and	sensitive	information	and	we	
will	do	our	best	to	make	you	as	comfortable	as	possible;	should	you	feel	uncomfortable	at	any	point	you	
are	 free	 to	 withdraw	 from	 the	 study.	 All	 information	 regarding	 the	 menstrual	 cycle	 is	 only	 used	 to	
ensure	that	our	testing	days	are	done	at	the	appropriate	times,	this	information	will	not	be	included	in	
any	 publications	 or	 presentations	 and	 the	 participant	 will	 not	 be	 identifiable	 by	 the	 information	 the	
provide.	There	is	a	possibility	of	mild	muscle	soreness	and/or	fatigue	typical	of	an	exercise	session.		You	
may	feel	some	discomfort	due	to	the	intensity	of	the	training	typical	of	strenuous	physical	exertion,	as	
you	are	required	to	perform	the	training	and	testing	sessions	with	maximal	effort.	Although	phlebotomy	
is	safe	when	done	by	certified	and	training	 individuals	 there	 is	a	small	 risk	of	bruising	at	 the	puncture	
site	 which	 can	 be	 reduced	 by	 keeping	 pressure	 on	 the	 site	 for	 several	 minutes	 after	 the	 needle	 is	
withdrawn.	In	some	rare	cases	the	vein	may	become	inflamed	after	the	sample	is	withdrawn	however	
using	a	warm	compress	can	alleviate	this.	There	 is	a	small	risk	of	 infection	any	time	the	skin	 is	broken	
however	 this	 rarely	 occurs	when	 equipment	 is	 properly	 sterilized	 and	 disposed	 of.	 Some	people	may	
also	 experience	 light-headedness	 if	 they	 are	 uncomfortable	 with	 needles	 and	 if	 this	 occurs	 the	
experiment	 will	 be	 terminated	 immediately.	 The	 risk	 of	 falling	 if	 this	 occurs	 is	 minimum	 as	 the	
participant	will	be	seated	in	a	secure	phlebotomy	chair.		
POTENTIAL	BENEFITS	TO	SUBJECTS	AND/OR	SOCIETY	
The	 potential	 benefits	 of	 your	 participation	 in	 this	 study	 include	 an	 improvement	 in	 your	 exercise	
capacity	 using	 a	 novel,	 time-efficient	 training	 modality	 as	 well	 gain	 a	 better	 understanding	 of	 your	
cardiorespiratory	fitness.	Results	from	this	study	will	further	our	understanding	of	high-intensity	interval	
training	 and	 its	 effects	 on	 energy	 expenditure	 as	 well	 as	 participant’s	 feelings	 towards	 these	
modifications	of	this	intense	form	of	training.	
CONFIDENTIALITY	
All	information	obtained	in	connection	with	this	study	will	be	de-identified.		All	contact	information	is	
collected	and	stored	on	a	master	list	in	a	password-protected	file	with	access	to	only	the	study	
investigators.		All	participants	will	be	assigned	an	arbitrary	number	to	ensure	anonymity.		This	study	
number	will	be	used	in	all	data	collection	files	and	mean	data	will	be	stored	in	a	password	protected	file	
for	comparison	with	future	studies.		Raw	data	will	not	be	released	to	any	other	parties	and	all	results	will	
be	collapsed	before	analysis.	All	blood	samples	will	be	stored	in	a	secured	location	until	analysis	and	
subsequently	destroyed.		
PARTICIPATION	AND	WITHDRAWAL	
Your	participation	in	this	research	study	is	completely	voluntary.		If	you	are	a	student	and	volunteer	to	
be	in	this	study,	you	may	withdraw	at	any	time	without	any	effect	on	your	status	at	Wilfrid	Laurier	
University.		If	you	are	not	a	student,	you	may	withdraw	at	any	time.		You	may	also	refuse	to	answer	any	
questions	you	feel	are	inappropriate	and	still	remain	in	the	study.		The	investigators	may	withdraw	you	
from	this	research	if	circumstances	arise	which	warrant	doing	so	(i.e.	lack	of	effort	during	exercise	
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sessions,	difficulty	scheduling,	repeatedly	missing	scheduled	sessions,	etc.).	Please	note	that	should	you	
withdraw	from	the	study	all	personal	information	and	blood	samples	will	be	immediately	destroyed.		
FEEDBACK	OF	THE	RESULTS	OF	THIS	STUDY	
If	you	would	like	a	copy	of	a	lay	summary	of	the	results	please	check	the	box	below.		The	results	from	
this	study	will	be	reported	in	general	terms	in	the	form	of	speech	or	writing	that	may	be	represented	in	
manuscripts	submitted	for	publication	in	scientific	journals,	or	oral	and/or	poster	presentations	at	
scientific	meetings,	seminars,	and/or	conferences.		We	plan	to	publish	this	study	in	an	academic	journal.		
The	information	published	in	a	journal	or	subsequent	studies	will	not	identify	you	in	any	way.		Copies	
will	be	available	upon	request.	
	
SUBSEQUENT	USE	OF	DATA	
This	de-identified	data	may	be	used	in	subsequent	studies	(with	no	link	to	your	personal	information).		
You	will	receive	a	copy	of	the	consent	form	after	it	has	been	signed	and	do	not	waive	any	legal	rights	by	
signing	it.	
------------------------------------------------------------------------------------------------------------	
This	letter	is	yours	to	keep.		If	you	have	any	questions	about	this	research	project	feel	free	to	call:	
Dr.	Tom	Hazell	519-884-1970	x3048	
Further,	if	you	have	any	questions	about	the	conduct	of	this	study	or	your	rights	as	a	research	subject	
you	may	contact	Dr.	R.	Basso,	Research	Ethics	Board	(REB)	Chair	(rbasso@wlu.ca	/	519-884-0710	x4994).	
Sincerely,	
Logan	Townsend	(town9000@mylaurier.ca),	MSc	Student	
Hashim	Islam	(isla9020@mylaurier.ca),	MSc	Student	
Dr.	Tom	Hazell	(thazell@wlu.ca),	Assistant	Professor	
Department	of	Kinesiology	and	Physical	Education,	Wilfrid	Laurier	University,	Waterloo,	ON	
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Title	of	Study:	The	Effect	of	Menstrual	Phase	on	Energy	Regulating	Hormones	in	Response	to	Sprint-
Interval	Training	(REB	#3862)	
	
Consent	Statement	
Principal	Investigators:	Dr.	Tom	Hazell	
I	have	read	the	accompanying	“Letter	of	Information”	and	have	had	the	nature	of	the	study	and	
procedures	to	be	used	explained	to	me.		All	of	my	questions	have	been	answered	to	my	satisfaction.	
By	signing	below,	I	agree	to	participate	in	this	study	
	
NAME	(please	print):						______________________________________	
	
SIGNATURE:						______________________________________	
DATE:						______________________________________	
	
	
NAME	OF	PERSON	OBTAINING	INFORMED	CONSENT	(please	print):	
					
		______________________________________	
SIGNATURE	OF	PERSON	OBTAINING	INFORMED	CONSENT:	
	
						______________________________________	
DATE:						______________________________________	
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Appendix V: Correlations 
 
 
 
 
 
 
 
 
 
Estradiol Progesterone AG GLP-1 
FP OP LP FP OP LP FP OP LP FP OP LP 
Estradiol - - - - - - 0.13 -0.41 -0.76* 0.69 0.75* 0.82* 
Progesterone - - - - - - -0.26 0.18 -0.46 0.19 0.42 0.54 
AG 0.13 -0.41 -0.76* -0.26 0.18 -0.46 - - - - - - 
GLP-1 0.69 0.75* 0.82* 0.19 0.42 0.54 - - - - - - 
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Appendix VI: Individual Sex Hormone Concentrations 
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Appendix VII: Absolute Concentrations of AG and GLP-1 
 
 
AG: 
 Fasting 
30 min 
post-prandial 
60 min 
post-prandial 
90 min 
post-prandial 
Follicular 524.0±394.4 354.8±205.4 333.1±157.1 397.6±161.2 
Ovulatory 576.1±422.9 378.5±163.1 343.7±165.8 416.4±221.7 
Luteal 607.6±268.7 474.0±266.4 388.9±220.5 534.1±283.9 
 
 
 
GLP-1: 
 Fasting 
30 min 
post-prandial 
60 min 
post-prandial 
90 min 
post-prandial 
Follicular 8.0±1.9 9.1±2.6 8.9±2.3 8.4±1.9 
Ovulatory 7.6±1.2 9.2±2.9 9.7±2.6 8.2±1.7 
Luteal 7.9±1.9 9.9±3.1 9.6±3.9 8.7±2.7 
 
 
